查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2037385

生物活性護膚市場：預測（至2034年）－按產品類型、膚質、原料來源、劑型、應用、通路、最終用戶和地區分類的全球分析

Postbiotic Skincare Market Forecasts to 2034 - Global Analysis By Product Type, Skin Type, Ingredient Source, Form, Application, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球益生元護膚市場將達到 64 億美元，並在預測期內以 18.4% 的複合年成長率成長，到 2034 年達到 248 億美元。

後生元護膚是指添加了透過細菌發酵過程產生的生物活性化合物的化妝品和皮膚科產品，例如胜肽、有機酸、胞外多醣、脂磷壁酸以及其他去活化益生菌的結構成分。這些產品已被證實具有多種皮膚健康益處，包括增強皮膚屏障功能、減輕發炎、誘導抗菌肽的產生以及支持皮膚微生物多樣性。它們也廣泛應用於臉部護膚、潔面、屏障修復、身體保養、頭皮護理以及針對敏感肌、乾性肌、油性肌、混合肌和老化肌的皮膚科護膚系列，同時避免了外用配方中活性益生菌所帶來的穩定性和安全性問題。

微生物組護膚類的科學成熟

皮膚微生物組科學的進步，為後生元化合物獨特的皮膚健康機制提供了強力的、經同行評審的科學證據，使得後生元護膚從一種單純的、推測性的健康潮流，發展成為經臨床驗證的高階護膚類。這贏得了皮膚科醫生的支持，也獲得了醫學美容專業人士的推薦。與使用活性益生菌的局部製劑相比，後生元成分的穩定性和安全性優勢，使其成為具有商業性可行性的微生物組護膚成分。因此，對於致力於以微生物組為中心進行產品開發並面向廣泛零售通路的大型化妝品製造商而言，後生元已成為他們的首選。

後生元消費者教育的投資需求

由於消費者對後生元並不熟悉，而且益生菌、益生元和其他護膚概念之間存在術語差異，品牌需要投入大量資源進行消費者教育，以闡明後生元獨特的作用機制，從而證明其高階產品定位的合理性。如果缺乏充分的教育，消費者可能會誤將後生元產品的功效歸因於他們對更廣泛的微生物護膚類的認知，而不是特定後生元化合物的作用。因此，與價格較低的同類益生菌和益生元護膚產品相比，高階後生元配方產品能夠設定更高價格的能力受到限制。

透過皮膚科臨床管道擴大分銷範圍

在皮膚科領域，益生元護膚品作為濕疹、酒糟、痤瘡以及術後皮膚微生物群恢復的輔助性治療，其應用打造了一個高階的專業配銷通路，該管道擁有更高的消費者信任度，並使其價格高於普通零售市場。理膚泉和雅漾等品牌建立的藥房直銷皮膚科品牌模式，顯示透過開發皮膚科醫生推薦的管道，經臨床驗證的微生物群護膚品牌可以實現商業性規模化。

生物益生菌護膚類的混亂

消費者對各種護膚產品類型——活性益生菌、益生元和後生元——的困惑，使得購買決策變得複雜。因此，消費者往往傾向選擇知名度高、消費者認可度高的知名益生元護膚品牌推出的「活性益生菌」產品。這可能會限制消費者嘗試後生元品牌的機會。這是因為，儘管後生元產品擁有更優異的配方穩定性和臨床證據，並得到了藥學專家的認可，但普通護膚消費者在零售購買時可能難以充分區分這些差異。

新冠疫情的影響：

新冠疫情期間，口罩佩戴和衛生習慣的改變導致皮膚微生物群失衡現象普遍存在。這促使消費者透過皮膚科醫生在社群媒體上發布的內容，了解疫情期間皮膚問題的管理，從而提高了對皮膚微生物群重要性的認知，並使後生元護膚成分的認知度超越了專業配方知識的範疇。疫情時代，消費者對皮膚健康科學的教育仍在持續，這進一步推動了微生物群護膚類的擴張，後生元配方也獲得了越來越多的臨床和消費者認可。

在預測期內，皮膚科護膚產品細分市場預計將佔據最大的市場佔有率。

在預測期內，皮膚科護膚品細分市場預計將佔據最大的市場佔有率。這是因為，經皮膚科醫生和藥劑師推薦的臨床皮膚科益生元護膚品系列，相較於大眾市場護膚品，具有更高的消費者信任度和治療方案依從性，從而能夠實現更高的溢價。定位為臨床皮膚微生物組品牌的品牌，例如理膚泉、雅漾和嘉琳，在益生元護膚市場中擁有最高的單價。

在預測期內，敏感肌膚細分市場預計將呈現最高的複合年成長率。

在預測期內，敏感肌膚細分市場預計將呈現最高的成長率。這是因為消費者越來越意識到，敏感肌膚症狀（如泛紅、反應和屏障功能受損）與微生物群失調有關，而後生元化合物可透過已證實有效的抗菌肽誘導和屏障功能修復機制，特異性解決這一問題。全球敏感肌膚人群估計佔已開發市場成年人口的50%以上，這是一個龐大且不斷成長的群體，使其成為後生元護膚產品開發的最大目標群體。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這是因為美國擁有全球最具科學意識的高階護膚消費市場，擁有完善的專業零售體系，能夠支持臨床益生元護膚品牌的銷售；TULA、Glowbiotics、Mother Dirt 和 La Roche-Posay 等領先品牌正在顯著推動北美益生元護膚的銷售；此外，美國根深蒂固的皮膚科醫生的推薦文化也促進了權威的臨床推薦文化。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要歸功於韓國的K-Beauty產業在發酵成分和益生元護膚技術領域的先行地位，提升了區域消費者對微生物護膚理念的認知；中國、日本和東南亞消費者對臨床護膚的投資迅速成長；以及國內領先的益生元護膚品牌不斷創新，打造出具有全球影響力的產品形態。

免費客製化服務：

訂閱本報告的用戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 對其他公司（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣量身定做的主要國家/地區的市場估算、預測和複合年成長率（註：基於可行性檢查）
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 成長要素、挑戰與機遇
  • 競爭格局概述
  • 戰略考慮和建議

第2章：分析框架

  • 分析的目標和範圍
  • 相關人員分析
  • 分析的前提條件與限制
  • 分析方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 科技與創新趨勢
  • 新興市場和高成長市場
  • 監管和政策環境
  • 感染疾病的影響及恢復前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商議價能力
    • 買方的議價能力
    • 替代產品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球後生技護膚市場：依產品類型分類

  • 臉部護膚
    • 美容精華液
    • 保濕霜
    • 洗面乳
  • 清潔劑和屏障修復產品
  • 身體保養產品形式
  • 頭皮護理和治療
  • 皮膚科護膚產品系列

第6章：全球後生技護膚市場：依膚質分類

  • 敏感肌膚
  • 乾性皮膚
  • 油性肌膚/易長痘肌膚
  • 混合性肌膚
  • 老化肌膚

第7章：全球後生物護膚市場：依原料來源分類

  • 乳酸菌衍生的
  • 雙歧桿菌衍生的
  • 源自釀酒酵母
  • 裂解液與去活化細胞

第8章：全球後生物活性護膚市場：以劑型分類

  • 奶油
  • 美容精華液
  • 凝膠
  • 薄霧

第9章：全球後生技護膚市場：依應用領域分類

  • 屏障修復/敏感肌膚
  • 痤瘡微生物群平衡調整
  • 異位性皮膚炎的治療
  • 抗衰老用途
  • 治療後恢復

第10章：全球生物活性護膚市場：依通路分類

  • 量販店與電子商務
  • 專業美容院
  • 皮膚科診所
  • 藥局/藥局
  • DTC（直接面對消費者）

第11章：全球後生物護膚市場：依最終用戶分類

  • 個人消費者
  • 皮膚科專科診所
  • 醫療水療美容診所

第12章 全球後生技護膚市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第13章 戰略市場資訊

  • 產業加值網路與供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第14章 產業趨勢與策略舉措

  • 企業合併（M&A）
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第15章：公司簡介

  • L'Oreal Group
  • Unilever PLC
  • Procter & Gamble Company
  • Johnson & Johnson Services, Inc.
  • The Estee Lauder Companies Inc.
  • La Roche-Posay
  • Avene（Pierre Fabre）
  • Gallinee Ltd.
  • Glowbiotics Inc.
  • Mother Dirt, Inc.
  • Esse Skincare
  • Tula Skincare
  • Biossance
  • Beekman 1802
  • Aurelia London
  • Columbia SkinCare
Product Code: SMRC35798

According to Stratistics MRC, the Global Postbiotic Skincare Market is accounted for $6.4 billion in 2026 and is expected to reach $24.8 billion by 2034 growing at a CAGR of 18.4% during the forecast period. Postbiotic skincare refers to cosmetic and dermatological products formulated with bioactive compounds generated through bacterial fermentation processes including peptides, organic acids, exopolysaccharides, lipoteichoic acids, and other structural components of inactivated probiotic bacteria that exert documented skin health benefits including barrier function reinforcement, inflammation reduction, antimicrobial peptide induction, and microbiome diversity support without the stability and safety challenges of live probiotic organisms in topical formulations, delivered across facial skincare, cleanser and barrier repair, body care, scalp treatment, and dermatological skincare line applications for sensitive, dry, oily, combination, and aging skin types.

Market Dynamics:

Driver:

Microbiome Skincare Category Scientific Maturation

Skin microbiome science advancement generating robust peer-reviewed evidence for postbiotic compound-specific skin health mechanisms has elevated postbiotic skincare from speculative wellness trend to clinically substantiated premium skincare category attracting dermatologist endorsement and medical aesthetic professional recommendation. The stability and safety advantages of postbiotic ingredients over live probiotic topical formulation challenges have positioned postbiotics as the commercially viable microbiome skincare ingredient format preferred by mainstream cosmetic manufacturers investing in microbiome-positioned product development for broad retail distribution.

Restraint:

Postbiotic Consumer Education Investment Requirements

Consumer unfamiliarity with the postbiotic terminology distinction from probiotic and prebiotic skincare concepts requires substantial brand consumer education investment to communicate specific postbiotic mechanism differentiation that justifies premium product positioning. Without adequate education, consumers may misattribute postbiotic product benefit to broader microbiome skincare category awareness rather than specific postbiotic compound activity, limiting ability to charge premium prices for sophisticated postbiotic formulations versus comparably positioned probiotic or prebiotic skincare alternatives available at lower price points.

Opportunity:

Dermatology Clinical Channel Distribution Growth

Dermatology practice adoption of postbiotic skincare as adjunct therapy for eczema, rosacea, acne, and post-procedure skin microbiome restoration creates a premium professional distribution channel generating superior consumer confidence and price premium justification compared to mass retail positioning. La Roche-Posay and Avene established pharmacy dermatology brand models demonstrate the commercial scale achievable through dermatologist recommendation channel development for clinically substantiated microbiome skincare brands.

Threat:

Live Probiotic Skincare Category Confusion

Consumer confusion between live probiotic, prebiotic, and postbiotic skincare product categories creating purchase decision complexity that may default toward more familiar live probiotic positioning with stronger existing consumer brand recognition from established probiotic skincare pioneers, potentially limiting postbiotic brand consumer trial generation despite superior formulation stability and clinical evidence foundations that specialist formulation science audiences recognize but mainstream skincare consumers may not meaningfully differentiate in retail purchase contexts.

Covid-19 Impact:

COVID-19 mask-wearing and pandemic hygiene disruption generating widespread skin microbiome imbalance created consumer awareness of skin microbiome importance through dermatologist social media content addressing pandemic skin condition management, expanding postbiotic skincare ingredient awareness beyond specialist formulation audiences. Post-pandemic sustained skin health science consumer education culture continues driving microbiome skincare category expansion with postbiotic formulations gaining increasing clinical and consumer recognition.

The dermatological skincare lines segment is expected to be the largest during the forecast period

The dermatological skincare lines segment is expected to account for the largest market share during the forecast period, due to the highest premium pricing achievable from clinical dermatological postbiotic skincare product lines endorsed through dermatologist and pharmacy professional recommendation channels that generate superior consumer confidence and treatment protocol compliance versus mass market skincare alternatives. La Roche-Posay, Avene, and Gallinee positioning as clinical skin microbiome brands commands the highest per-unit retail value within the postbiotic skincare market.

The sensitive skin segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the sensitive skin segment is predicted to witness the highest growth rate, driven by accelerating consumer awareness that skin sensitivity symptoms including redness, reactivity, and barrier disruption are linked to microbiome dysbiosis that postbiotic compounds specifically address through documented antimicrobial peptide induction and barrier function restoration mechanisms. The large and growing global sensitive skin population estimated at over 50 percent of adults in developed markets represents the highest-volume target demographic for postbiotic skincare commercial development.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most scientifically engaged premium skincare consumer market with established specialty retailer infrastructure supporting clinical postbiotic skincare brand distribution, leading brands including TULA, Glowbiotics, Mother Dirt, and La Roche-Posay generating substantial North American postbiotic skincare revenue, and strong dermatologist recommendation culture driving authoritative clinical product guidance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to South Korean K-beauty industry pioneering fermented ingredient and postbiotic skincare technology generating strong regional consumer familiarity with microbiome skincare concepts, rapidly growing clinical skincare investment among Chinese, Japanese, and Southeast Asian consumers, and strong domestic postbiotic skincare brand innovation creating globally influential product formats.

Key players in the market

Some of the key players in Postbiotic Skincare Market include L'Oreal Group, Unilever PLC, Procter & Gamble Company, Johnson & Johnson Services Inc., The Estee Lauder Companies Inc., La Roche-Posay, Avene (Pierre Fabre), Gallinee Ltd., Glowbiotics Inc., Mother Dirt Inc., Esse Skincare, Tula Skincare, Biossance, Beekman 1802, Aurelia London, and Columbia SkinCare.

Key Developments:

In April 2026, La Roche-Posay launched a new postbiotic sensitive skin range featuring clinically validated Lipikar postbiotic complex demonstrating significant barrier restoration and microbiome diversity improvement in a 6-week dermatologist-supervised clinical study across 200 sensitive skin participants.

In March 2026, TULA Skincare introduced a postbiotic acne-prone skin collection combining clinically validated Lactobacillus lysate postbiotics with niacinamide and azelaic acid demonstrating superior sebum regulation and comedone reduction versus probiotic-only formulations.

In March 2026, Gallinee Ltd. secured European pharmacy chain expansion placing its postbiotic facial care range in 1,800 additional pharmacy locations across France, Germany, and Benelux following clinical data publication validating microbiome diversity improvement outcomes.

Product Types Covered:

  • Facial Skincare
  • Cleansers & Barrier-repair Products
  • Body Care Formulations
  • Scalp Care & Treatments
  • Dermatological Skincare Lines

Skin Types Covered:

  • Sensitive Skin
  • Dry Skin
  • Oily & Acne-Prone Skin
  • Combination Skin
  • Aging Skin

Ingredient Sources Covered:

  • Lactobacillus-Derived
  • Bifidobacterium-Derived
  • Saccharomyces cerevisiae-Derived
  • Lysates vs. Inactivated Cells

Forms Covered:

  • Creams
  • Serums
  • Gels
  • Mists

Applications Covered:

  • Barrier Repair & Sensitivity
  • Acne & Microbiome Balancing
  • Atopic Dermatitis Care
  • Anti-aging Applications
  • Post-procedure Recovery

Distribution Channels Covered:

  • Mass Retail & E-commerce
  • Specialty Beauty Stores
  • Dermatology Clinics
  • Pharmacies & Drugstores
  • Direct-to-Consumer

End Users Covered:

  • Individual Consumers
  • Professional Dermatology Practices
  • MedSpas & Aesthetic Clinics

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Postbiotic Skincare Market, By Product Type

  • 5.1 Facial Skincare
    • 5.1.1 Serums
    • 5.1.2 Moisturizers
    • 5.1.3 Cleansers
  • 5.2 Cleansers & Barrier-repair Products
  • 5.3 Body Care Formulations
  • 5.4 Scalp Care & Treatments
  • 5.5 Dermatological Skincare Lines

6 Global Postbiotic Skincare Market, By Skin Type

  • 6.1 Sensitive Skin
  • 6.2 Dry Skin
  • 6.3 Oily & Acne-Prone Skin
  • 6.4 Combination Skin
  • 6.5 Aging Skin

7 Global Postbiotic Skincare Market, By Ingredient Source

  • 7.1 Lactobacillus-Derived
  • 7.2 Bifidobacterium-Derived
  • 7.3 Saccharomyces cerevisiae-Derived
  • 7.4 Lysates vs. Inactivated Cells

8 Global Postbiotic Skincare Market, By Form

  • 8.1 Creams
  • 8.2 Serums
  • 8.3 Gels
  • 8.4 Mists

9 Global Postbiotic Skincare Market, By Application

  • 9.1 Barrier Repair & Sensitivity
  • 9.2 Acne & Microbiome Balancing
  • 9.3 Atopic Dermatitis Care
  • 9.4 Anti-aging Applications
  • 9.5 Post-procedure Recovery

10 Global Postbiotic Skincare Market, By Distribution Channel

  • 10.1 Mass Retail & E-commerce
  • 10.2 Specialty Beauty Stores
  • 10.3 Dermatology Clinics
  • 10.4 Pharmacies & Drugstores
  • 10.5 Direct-to-Consumer

11 Global Postbiotic Skincare Market, By End User

  • 11.1 Individual Consumers
  • 11.2 Professional Dermatology Practices
  • 11.3 MedSpas & Aesthetic Clinics

12 Global Postbiotic Skincare Market, By Geography

  • 12.1 North America
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Mexico
  • 12.2 Europe
    • 12.2.1 United Kingdom
    • 12.2.2 Germany
    • 12.2.3 France
    • 12.2.4 Italy
    • 12.2.5 Spain
    • 12.2.6 Netherlands
    • 12.2.7 Belgium
    • 12.2.8 Sweden
    • 12.2.9 Switzerland
    • 12.2.10 Poland
    • 12.2.11 Rest of Europe
  • 12.3 Asia Pacific
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 South Korea
    • 12.3.5 Australia
    • 12.3.6 Indonesia
    • 12.3.7 Thailand
    • 12.3.8 Malaysia
    • 12.3.9 Singapore
    • 12.3.10 Vietnam
    • 12.3.11 Rest of Asia Pacific
  • 12.4 South America
    • 12.4.1 Brazil
    • 12.4.2 Argentina
    • 12.4.3 Colombia
    • 12.4.4 Chile
    • 12.4.5 Peru
    • 12.4.6 Rest of South America
  • 12.5 Rest of the World (RoW)
    • 12.5.1 Middle East
      • 12.5.1.1 Saudi Arabia
      • 12.5.1.2 United Arab Emirates
      • 12.5.1.3 Qatar
      • 12.5.1.4 Israel
      • 12.5.1.5 Rest of Middle East
    • 12.5.2 Africa
      • 12.5.2.1 South Africa
      • 12.5.2.2 Egypt
      • 12.5.2.3 Morocco
      • 12.5.2.4 Rest of Africa

13 Strategic Market Intelligence

  • 13.1 Industry Value Network and Supply Chain Assessment
  • 13.2 White-Space and Opportunity Mapping
  • 13.3 Product Evolution and Market Life Cycle Analysis
  • 13.4 Channel, Distributor, and Go-to-Market Assessment

14 Industry Developments and Strategic Initiatives

  • 14.1 Mergers and Acquisitions
  • 14.2 Partnerships, Alliances, and Joint Ventures
  • 14.3 New Product Launches and Certifications
  • 14.4 Capacity Expansion and Investments
  • 14.5 Other Strategic Initiatives

15 Company Profiles

  • 15.1 L'Oreal Group
  • 15.2 Unilever PLC
  • 15.3 Procter & Gamble Company
  • 15.4 Johnson & Johnson Services, Inc.
  • 15.5 The Estee Lauder Companies Inc.
  • 15.6 La Roche-Posay
  • 15.7 Avene (Pierre Fabre)
  • 15.8 Gallinee Ltd.
  • 15.9 Glowbiotics Inc.
  • 15.10 Mother Dirt, Inc.
  • 15.11 Esse Skincare
  • 15.12 Tula Skincare
  • 15.13 Biossance
  • 15.14 Beekman 1802
  • 15.15 Aurelia London
  • 15.16 Columbia SkinCare

List of Tables

  • Table 1 Global Postbiotic Skincare Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Postbiotic Skincare Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Postbiotic Skincare Market Outlook, By Facial Skincare (2023-2034) ($MN)
  • Table 4 Global Postbiotic Skincare Market Outlook, By Serums (2023-2034) ($MN)
  • Table 5 Global Postbiotic Skincare Market Outlook, By Moisturizers (2023-2034) ($MN)
  • Table 6 Global Postbiotic Skincare Market Outlook, By Cleansers (2023-2034) ($MN)
  • Table 7 Global Postbiotic Skincare Market Outlook, By Cleansers & Barrier-repair Products (2023-2034) ($MN)
  • Table 8 Global Postbiotic Skincare Market Outlook, By Body Care Formulations (2023-2034) ($MN)
  • Table 9 Global Postbiotic Skincare Market Outlook, By Scalp Care & Treatments (2023-2034) ($MN)
  • Table 10 Global Postbiotic Skincare Market Outlook, By Dermatological Skincare Lines (2023-2034) ($MN)
  • Table 11 Global Postbiotic Skincare Market Outlook, By Skin Type (2023-2034) ($MN)
  • Table 12 Global Postbiotic Skincare Market Outlook, By Sensitive Skin (2023-2034) ($MN)
  • Table 13 Global Postbiotic Skincare Market Outlook, By Dry Skin (2023-2034) ($MN)
  • Table 14 Global Postbiotic Skincare Market Outlook, By Oily & Acne-Prone Skin (2023-2034) ($MN)
  • Table 15 Global Postbiotic Skincare Market Outlook, By Combination Skin (2023-2034) ($MN)
  • Table 16 Global Postbiotic Skincare Market Outlook, By Aging Skin (2023-2034) ($MN)
  • Table 17 Global Postbiotic Skincare Market Outlook, By Ingredient Source (2023-2034) ($MN)
  • Table 18 Global Postbiotic Skincare Market Outlook, By Lactobacillus-Derived (2023-2034) ($MN)
  • Table 19 Global Postbiotic Skincare Market Outlook, By Bifidobacterium-Derived (2023-2034) ($MN)
  • Table 20 Global Postbiotic Skincare Market Outlook, By Saccharomyces cerevisiae-Derived (2023-2034) ($MN)
  • Table 21 Global Postbiotic Skincare Market Outlook, By Lysates vs. Inactivated Cells (2023-2034) ($MN)
  • Table 22 Global Postbiotic Skincare Market Outlook, By Form (2023-2034) ($MN)
  • Table 23 Global Postbiotic Skincare Market Outlook, By Creams (2023-2034) ($MN)
  • Table 24 Global Postbiotic Skincare Market Outlook, By Serums (2023-2034) ($MN)
  • Table 25 Global Postbiotic Skincare Market Outlook, By Gels (2023-2034) ($MN)
  • Table 26 Global Postbiotic Skincare Market Outlook, By Mists (2023-2034) ($MN)
  • Table 27 Global Postbiotic Skincare Market Outlook, By Application (2023-2034) ($MN)
  • Table 28 Global Postbiotic Skincare Market Outlook, By Barrier Repair & Sensitivity (2023-2034) ($MN)
  • Table 29 Global Postbiotic Skincare Market Outlook, By Acne & Microbiome Balancing (2023-2034) ($MN)
  • Table 30 Global Postbiotic Skincare Market Outlook, By Atopic Dermatitis Care (2023-2034) ($MN)
  • Table 31 Global Postbiotic Skincare Market Outlook, By Anti-aging Applications (2023-2034) ($MN)
  • Table 32 Global Postbiotic Skincare Market Outlook, By Post-procedure Recovery (2023-2034) ($MN)
  • Table 33 Global Postbiotic Skincare Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 34 Global Postbiotic Skincare Market Outlook, By Mass Retail & E-commerce (2023-2034) ($MN)
  • Table 35 Global Postbiotic Skincare Market Outlook, By Specialty Beauty Stores (2023-2034) ($MN)
  • Table 36 Global Postbiotic Skincare Market Outlook, By Dermatology Clinics (2023-2034) ($MN)
  • Table 37 Global Postbiotic Skincare Market Outlook, By Pharmacies & Drugstores (2023-2034) ($MN)
  • Table 38 Global Postbiotic Skincare Market Outlook, By Direct-to-Consumer (2023-2034) ($MN)
  • Table 39 Global Postbiotic Skincare Market Outlook, By End User (2023-2034) ($MN)
  • Table 40 Global Postbiotic Skincare Market Outlook, By Individual Consumers (2023-2034) ($MN)
  • Table 41 Global Postbiotic Skincare Market Outlook, By Professional Dermatology Practices (2023-2034) ($MN)
  • Table 42 Global Postbiotic Skincare Market Outlook, By MedSpas & Aesthetic Clinics (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.